Literature DB >> 2536004

Cellular interactions determining the production of collagenase by a rat mammary carcinoma cell line.

J G Lyons1, K Siew, R L O'Grady.   

Abstract

The cellular interactions regulating the production of collagenase by a cell line derived from a spontaneously arising rat mammary carcinoma have been studied. The cell line, BC1, was grown permanently under defined serum-free conditions, so that the poorly characterized and variable effects of serum on collagenase expression were avoided. Two stable subpopulations of cells present in BC1 cultures were defined as epithelioid cells ("E-cells") and myoepithelioid cells ("M-cells"). These subpopulations differed in their morphology, pattern of growth and susceptibility to detachment from culture vessels by trypsin. Seven clones of M-cells and 7 clones of E-cells, obtained by the limiting dilution technique, were used to determine the cellular source of collagenase and the interactions which led to its expression. M-cells displayed an absolute dependence on a soluble factor produced by E-cells for their survival in vitro. The presence of both cellular types in culture was necessary for collagenase secretion to occur, E-cells being the major source of enzyme in mixed cultures. A soluble factor produced by M-cells was largely, if not completely, responsible for the induction of collagenase secretion by E-cells. Clones representative of both subpopulations were tumorigenic in syngeneic host animals. These results suggest that the phenotypic diversity which occurs within populations of neoplastic cells may give rise to subpopulations of cells which display a more aggressive phenotype in coexistence than in isolation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536004     DOI: 10.1002/ijc.2910430123

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

Review 1.  Serum-free culture of carcinoma cell lines.

Authors:  P Collodi; C Rawson; D Barnes
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

Review 2.  Clonal cooperativity in heterogenous cancers.

Authors:  Hengbo Zhou; Deepika Neelakantan; Heide L Ford
Journal:  Semin Cell Dev Biol       Date:  2016-08-28       Impact factor: 7.727

Review 3.  Cellular interactions in metastasis.

Authors:  F R Miller; G H Heppner
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

Review 4.  Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.

Authors:  Deepika Neelakantan; David J Drasin; Heide L Ford
Journal:  Cell Adh Migr       Date:  2014-10-16       Impact factor: 3.405

5.  Autocrine and paracrine growth factors in tumor growth: a mathematical model.

Authors:  S Michelson; J Leith
Journal:  Bull Math Biol       Date:  1991       Impact factor: 1.758

Review 6.  Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions.

Authors:  J Guy Lyons; Erwin Lobo; Anna M Martorana; Mary R Myerscough
Journal:  Clin Exp Metastasis       Date:  2007-12-11       Impact factor: 5.150

7.  Protection of retinal ganglion cells by caspase substrate-binding peptide IQACRG from N-methyl-D-aspartate receptor-mediated excitotoxicity.

Authors:  Masaaki Seki; Walid Soussou; Shin-ichi Manabe; Stuart A Lipton
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-08       Impact factor: 4.799

Review 8.  ArcRNAs and the formation of nuclear bodies.

Authors:  Shinichi Nakagawa; Tomohiro Yamazaki; Taro Mannen; Tetsuro Hirose
Journal:  Mamm Genome       Date:  2021-06-03       Impact factor: 2.957

9.  Proteinase inhibitors in malignancy: therapeutic promise or another white elephant?

Authors:  D J Dodwell
Journal:  J R Soc Med       Date:  1993-10       Impact factor: 18.000

10.  Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture.

Authors:  R S Talhouk; J R Chin; E N Unemori; Z Werb; M J Bissell
Journal:  Development       Date:  1991-06       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.